NG35% | ORG35% | NG100% | ||||
Fixed input | Hazard ratio | P | Hazard ratio | P | Hazard ratio | P |
Disease stage | 0.1 | 0.1 | 0.1 | |||
I | 1 | 1 | 1 | |||
II | 0.2 (0.03–1.1) | 0.2 (0.03–1.1) | 0.2 (0.04–1.2) | |||
III | 1.7 (0.4–8.6) | 1.4 (0.3–7.2) | 1.8 (0.4–8.9) | |||
IV | 1.8 (0.3–12) | 1.7 (0.2–12) | 1.9 (0.3–13) | |||
Treatment | <0.0001* | <0.0001* | <0.0001* | |||
Surgery | 1 | 1 | 1 | |||
Chemoradiotherapy | 0.3 (0.1–0.6) | 0.3 (0.2–0.7) | 0.4 (0.1–1.8) | |||
Chemotherapy | 1.1 (0.5–2.4) | 1.1 (0.5–2.5) | 1.6 (0.3–8.3) | |||
Expectative (none) | 5.2 (2.2–12) | 4.5 (2.0–10) | 7.7 (1.5–40) | |||
Iterative backward selection | ||||||
Summed TLG | 1.07 (1.01–1.13) | 0.02* | 1.08 (1.02–1.14) | 0.009* | 1.07 (1.01–1.13) | 0.04* |
High-intensity emphasis | 0.997 (0.995–0.999) | 0.02* | 0.997 (0.995–0.999) | 0.02* | 0.997 (0.995–0.999) | 0.02* |
↵* Statistically significant.
Data in parentheses are 95% confidence intervals. Hazard ratios are per 100-unit change for TLG and per 1-unit change for other parameters.